News

The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.
The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...
Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...
ClearNote Health has secured the UK Conformity Assessed (UKCA) marking for the company's Avantect Pancreatic Cancer Test.
The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) for the treatment of atrial fibrillation (AF) within the NHS.
Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.
BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...
The US FDA has granted 510(k) clearance for Exactech’s Equinoxe Scapula Reconstruction System for acromial and scapular spine fractures.
The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.
MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.
USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.
Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.